Cite
HARVARD Citation
Shin, D. et al. (n.d.). IMMU-39. NANOPARTICLE TREATMENT REBALANCES IMMUNODOMINANCE OF ANTI-VIRUS IMMUNITY TO ENHANCE ANTI-TUMOR IMMUNITY DURING ONCOLYTIC ADENOVIRUS THERAPY IN SOLID TUMORS. Neuro-oncology. pp. vii139-vii140. [Online].